Noam VanderWalde, MD, MS
7945 Wolf River Boulevard
Germantown TN 38138 901.683.0055
Germantown TN 38138 901.683.0055
. Dr. Noam VanderWalde, is a national expert in the treatment of older adult cancer patients with radiation and sits on multiple national committees, including the Older Adult Oncology Committee for the National Comprehensive Cancer Network (NCCN), the Cancer in Older Adults Committee for the Alliance for Clinical Trials Cooperative Group, and the Older Adult Working Group for NRG Oncology. Dr. VanderWalde is a member of a number of national and international cancer groups, including the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), the Southwest Oncology Cooperative Group (SWOG), the Alliance for Clinical Trials in Oncology, the NRG Oncology Cooperative Group, the Cancer and Aging Research Group (CARG), and the International Society of Geriatric Oncology (SIOG).
Dr. VanderWalde graduated Magna Cum Laude with a bachelor’s degree in History from the University of Pennsylvania.
He completed his medical degree at the University of Maryland and was nominated to the Alpha Omega Alpha honors medical society.
He completed his Radiation Oncology residency at the University of North Carolina, and completed his Masters in epidemiology from the University of Tennessee Health Science Center shortly thereafter. Dr. VanderWalde is board certified by the American Board of Radiology in Radiation Oncology
- The University of Tennessee Health Science Center/West Cancer Center Outstanding Faculty Award, 2016-2017.
- The West Cancer Center Faculty Research Award, 2016
- The Roentgen Resident Research Award, 2014
- Conquer Cancer Foundation of ASCO Young Investigator Award, 2014
- Lineberger Comprehensive Cancer Center Clinical/Translational Developmental Research Award, 2013
- The Alpha Omega Alpha Postgraduate Award, 2012
- Director of Clinical Research, Department of Radiation Oncology, West Cancer Center
- Assistant Professor, the University of Tennessee Health Science Center
- Section Chair Institutional Review Board, University of Tennessee Health Science Center
Dr. VanderWalde is currently the primary investigator on multiple investigator initiated studies, including:
- PI: The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older
- Co-PI: Predicting Tolerance to Radiation Therapy in Older Adults with Cancer
- Co-PI: Radiation Adherence/Toxicity in Patients with Non-Ovarian Gynecological Cancers
- Site-PI: Neoadjuvant Chemoradiotherapy with CRLX-101 and Capecitabine for Rectal Cancer
Dr. VanderWalde has published numerous peer reviewed articles and has presented data at many national and international meetings on topics such as geriatric, head and neck cancer, breast cancer, bladder cancer, and health services research. To view Dr. VanderWalde's recent publications, click here.
Dr. VanderWalde is a member of a number of national groups, including the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), The American Medical Association (AMA), Alpha Omega Alpha (AOA), Southwest Oncology Cooperative Group (SWOG), the Alliance for Clinical Trials in Oncology, and the Cancer and Aging Research Group (CARG).